Vera Therapeutics, Inc. Board of Directors

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase III clinical trial for patients with immunoglobulin A nephropathy; and for treatment of lupus nephritis that is in Phase II clinical trial. It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.

Dr. Marshall W. Fordyce M.D.

Dr. Marshall W. Fordyce M.D.

Founder, President, CEO & Director

Mr. Joseph R. Young M.B.A.

Mr. Joseph R. Young M.B.A.

Senior VP of Finance & Chief Accounting Officer

Ms. Kelly Rauber

Ms. Kelly Rauber

Senior Vice President of Human Resources

Mr. Julien E. Capers J.D.

Mr. Julien E. Capers J.D.

Senior Vice President of Legal

Mr. Jason S Carter

Mr. Jason S Carter

Chief Legal Officer

Mr. Tom Doan

Mr. Tom Doan

Senior Vice President of Development Operations

Mr. Sean P. Grant M.B.A.

Mr. Sean P. Grant M.B.A.

Chief Financial Officer

Dr. Allen Ebens B.Sc., Ph.D.

Dr. Allen Ebens B.Sc., Ph.D.

Executive Vice President of Research

Ms. Lauren Frenz M.B.A.

Ms. Lauren Frenz M.B.A.

Chief Business Officer

Mr. David L. Johnson M.B.A.

Mr. David L. Johnson M.B.A.

Chief Opearating Officer

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.